Cargando…
THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation
Hepatocellular carcinoma (HCC) is the most common malignant liver tumor with high mortality and poor prognosis worldwide. This study aimed to identify hub genes and investigate the underlying molecular mechanisms in HCC progression by integrated bioinformatics analysis and experimental validation. B...
Autores principales: | Ding, Yuxi, Liu, Xiaoling, Yuan, Yue, Sheng, Yunjian, Li, Decheng, Ojha, Suvash Chandra, Sun, Changfeng, Deng, Cunliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908915/ https://www.ncbi.nlm.nih.gov/pubmed/35196258 http://dx.doi.org/10.18632/aging.203900 |
Ejemplares similares
-
AC093797.1 as a Potential Biomarker to Indicate the Prognosis of Hepatocellular Carcinoma and Inhibits Cell Proliferation, Invasion, and Migration by Reprogramming Cell Metabolism and Extracellular Matrix Dynamics
por: Liu, Xiaoling, et al.
Publicado: (2021) -
Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: a meta-analysis
por: Shi, Han, et al.
Publicado: (2019) -
Downregulation of THRSP Promotes Hepatocellular Carcinoma Progression by Triggering ZEB1 Transcription in an ERK-dependent Manner
por: Hu, Qiong, et al.
Publicado: (2021) -
Investigational drugs with dual activity against HBV and HIV (Review)
por: Sun, Shiyu, et al.
Publicado: (2021) -
LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis
por: Luo, Meiyan, et al.
Publicado: (2021)